These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14593750)

  • 61. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.
    Kälviäinen R; Aikiä M; Mervaala E; Saukkonen AM; Pitkänen A; Riekkinen PJ
    Epilepsy Res; 1996 Nov; 25(3):291-7. PubMed ID: 8956929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
    Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Seizure activity and off-label use of tiagabine.
    Flowers CM; Racoosin JA; Kortepeter C
    N Engl J Med; 2006 Feb; 354(7):773-4. PubMed ID: 16481654
    [No Abstract]   [Full Text] [Related]  

  • 65. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
    Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
    Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and EEG findings in complex partial status epilepticus with tiagabine.
    Trinka E; Moroder T; Nagler M; Staffen W; Löscher W; Ladurner G
    Seizure; 1999 Feb; 8(1):41-4. PubMed ID: 10091848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tiagabine for epilepsy.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
    [No Abstract]   [Full Text] [Related]  

  • 68. [Evaluation of tiagabine efficacy in different groups of patients with epilepsy].
    Jedrzejczak J
    Neurol Neurochir Pol; 2000; 34 Suppl 7():9-16. PubMed ID: 11253491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Gabitril as an additive drug in therapy of intractable epileptic seizures in children].
    Kmieć T; Jóźwiak S; Kuczyński D; Karkowska B; Bachański M
    Neurol Neurochir Pol; 2000; 34 Suppl 7():25-34. PubMed ID: 11253489
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tiagabine.
    Mengel H
    Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Tiagabine: a GABA-ergic anti-epileptic drug].
    Herranz JL
    Rev Neurol; 1997 Oct; 25(146):1607-10. PubMed ID: 9462992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tiagabine.
    Shinnar S
    Semin Pediatr Neurol; 1997 Mar; 4(1):24-33. PubMed ID: 9097364
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.
    Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE
    Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tiagabine: efficacy and safety in partial seizures - current status.
    Bauer J; Cooper-Mahkorn D
    Neuropsychiatr Dis Treat; 2008 Aug; 4(4):731-6. PubMed ID: 19043517
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Seizures in a pediatric patient with a tiagabine overdose.
    Kazzi ZN; Jones CC; Morgan BW
    J Med Toxicol; 2006 Dec; 2(4):160-2. PubMed ID: 18072137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of long-term treatment with tiagabine.
    Fakhoury T; Uthman B; Abou-Khalil B
    Seizure; 2000 Sep; 9(6):431-5. PubMed ID: 10986002
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effectiveness of adjunctive therapy with tiagabine in mentally disabled patients with epilepsy.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):226-36. PubMed ID: 12898928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.